More Imugene Ltd news
Imugene LtdASX: IMU

S&P DJI Announces March 2021 Quarterly Rebalance

Mar 12, 2021 at 6:23 AM EST · Issued by Imugene Ltd

Filed with ASX · Mar 12, 2021 at 6:23 AM EST · 9 pages · English

On 6ix: 6ix.com/news/sandp-dji-announces-march-2021-quarterly-rebalance-92

Imugene Ltd on 6ix

Earlier from Imugene

  • Imugene to Present HER-Vaxx Phase 2 Data at AACR21 MeetingMar 10, 2021
  • Imugene Commences Cohort 2 Dosing in Phase 1 PD1-VAXX TrialFeb 11, 2021
  • Imugene Dose Escalates in PD1-VAXX Phase 1 Clinical TrialJan 20, 2021
  • Imugene completes recruitment to HER-Vaxx Phase 2 trialimJan 6, 2021
  • Imugene Enrols First Cohort of PD1-Vaxx Clinical TrialDec 16, 2020

Later from Imugene

  • Final Highest Dose in Phase 1 Clinical Trial of PD-VAXXApr 6, 2021
  • Imugene Oncolytic Virus Presentation at AACR 2021 MeetingApr 11, 2021
  • Imugene announces clinical milestone for HER-VaxxApr 20, 2021
  • Appendix 4C - quarterlyApr 23, 2021
  • Prestigious Research Journal Publish HER-Vaxx Phase 1B DataApr 29, 2021
All Imugene news releases↗

Follow Imugene into a list and get an email when it puts out news.

Follow Imugene
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer